期刊文献+

剂量分割模式对肝癌放射治疗预后影响的探讨

下载PDF
导出
摘要 目的 对肝癌放射治疗的预后影响因素进行研究论述,并就剂量分割模式对肝癌放射治疗的预后影响进行详细分析.方法在我院2013年2月-2015年3月就诊的肝癌患者记录中选取120例作为本次研究对象,对患者的性别、CUPI评分和剂量分割模式的相关数据进行分析,并利用风险模型对CUPI评分系统、性别和剂量分割模式等影响肝癌放射治疗的预后因素和治疗后3年内的生存率进行相关分析.结果CUPI评分系统、性别和剂量分割模式共同构成了肝癌放射治疗的预后影响因素,且剂量分割模式具有比较理想的预后治疗影响,因此与CUPI评分系统和性别等因素相比,剂量分割模式对肝癌放射治疗的预后影响较为明显,可有效提高患者的生存率,其数据存在显著性差异,具有统计学意义(P<0.05).结论剂量分割模式可有利于提高肝癌患者的生存率,对肝癌放射治疗产生积极的预后影响.
作者 方志祥
机构地区 [
出处 《临床研究》 2016年第3期48-49,共2页 Clinical Research
  • 相关文献

参考文献1

二级参考文献17

  • 1梁世雄,蒋国梁,朱小东,傅小龙,黎福祥,黄启芳,王安宇,陈龙,陆海杰.原发性肝癌大分割三维适形放疗的预后因素分析[J].中华肿瘤杂志,2005,27(10):613-615. 被引量:13
  • 2曾昭冲.腹部肿瘤的放射治疗—— 肝细胞癌的放射治疗[J].实用肿瘤杂志,2007,22(5):380-384. 被引量:12
  • 3Leung TW,Tang AM,Zee B,et al. Construction of the Chi- nese University Prognostic Index for hepatocellular carcino- ma and comparison with the TNM staging system, the Oku- da staging system, and the Cancer of the Liver Italian Pro- gram staging system: a study based on 926 patients [ J ]. Cancer, 2002,94 ( 6 ) : 1760 - 1769.
  • 4Liang SX, Zhu XD, Lu H J, et al. Hypofractionated three-di- mensional conformal radiation therapy (3dcrt) for primary liver carcinoma[ J ]. Cancer,2005,103 ( 10 ) :2181 - 2188.
  • 5Cochrane AM, Murray-lyon IM, Brinkley DM, et al. quad- ruple chemotherapy versus radiotherapy in treatment of pri- mary hepatocellular carcinoma [ J ]. Cancer, 1977,40 ( 2 ) : 609 - 614.
  • 6Stillwagon GB, Order SE, Guse C, et al. 194 hepatocellular cancers treated by radiation and chemotherapy combina- tions: toxicity and response: a Radiation Therapy Oncology Group Study [J ]. Int J Radiat Oncol Biol Phys, 19g9, 17(6) :1223 - 1229.
  • 7Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unre- sectable hepatocellular carcinoma [ J ]. Int J Radiat OrLcoL Biol Phys, 1999,43 (2) :393 - 397.
  • 8Seong J, Park HC, Han KH, et al. Local Radiotherapy for Unresectable Hepatocellular Carcinoma Patients Who Failed with Transcatheter Arterial Chemoembolization [ J ]. Int J Radiat Oncol, Biology, Physics ,2000,47 ( 5 ) : 1331 - 1335.
  • 9Zeng ZC ,Tang ZY, Yang BH, et al. Comparison between ra- dioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma [ J ]. Eur J of Nucl Med Mol Imaging,2002,29(12) : 1657 - 1668.
  • 10Zeng ZC,Tang ZY,Wu ZQ,et al. Phase I clinical trial of o- ral furtulon and combined hepatic arterial chemoemboliza- tion and radiotherapy in unresectable primary liver cancers, including clinicopathologic study [ J ]. Am J Clin Oncol, 2000,23 ( 5 ) :449 - 454.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部